Ревматоидный артрит и поражение сердца – это действительно актуально?

А.П. Ребров

ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России

В статье представлены данные о клинически значимом поражении сердца у пациентов с ревматоидным артритом (РА), особенностях развития ишемической и неишемической болезни сердца с существенным повышением риска неблагоприятных сердечно-сосудистых событий. Для пациентов с РА характерно повышение риска развития инфаркта миокарда, сердечной недостаточности, нарушений ритма, внезапной сердечной смерти и общей сердечно-сосудистой смерти. Подчеркивается возможность достаточно быстрого развития дисфункции миокарда у пациентов с РА с момента манифестации заболевания, развития и прогрессирования атеросклероза коронарных артерий, а при развитии у больных РА поражения коронарных артерий установлена худшая выживаемость после перенесенного инфаркта. Имеющиеся факты позволяют говорить о ревматоидном артрите как о заболевании, вносящем существенный вклад в сердечно-сосудистую заболеваемость и смертность.

ключевые слова: ревматоидный артрит, сердце, миокард, атеросклероз коронарных артерий, сердечная недостаточность, сердечно-сосудистая смертность

для цитирования: А.П. Ребров. Ревматоидный артрит и поражение сердца – это действительно актуально? Неотложная кардиология и кардиоваскулярные риски, 2021, Т. 5, № 2, С. 1406–1410

Rheumatoid arthritis and heart disease – is it really relevant?

Andrey P. Rebrov

The article presents data on clinically significant heart impairment in patients with rheumatoid arthritis (RA), as well as features of the development of ischemic and non-ischemic heart disease with a significant increase in the risk of adverse cardiovascular events. Patients with RA are characterized by an increased risk of developing myocardial infarction, heart failure, rhythm disturbances, sudden cardiac death, and general cardiovascular death. The paper emphasizes the possibility of a fairly rapid development of myocardial dysfunction in patients with RA from the moment of manifestation of the disease, the development and progression of atherosclerosis of the coronary arteries. Besides, in case of the development of a coronary artery disease in RA patients, the worst survival rate after a heart attack was established. The available findings suggest that rheumatoid arthritis is a disease that makes a significant contribution to cardiovascular morbidity and mortality.

keywords: rheumatoid arthritis, heart, myocardium, atherosclerosis of the coronary, heart failure, arteriescardiovascular mortality

for references: Andrey P. Rebrov. Rheumatoid arthritis and heart disease – is it really relevant? Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2021, vol. 5, no. 2, pp. 1406–1410

References
1. Avina-Zubieta J. A., Thomas J., Sadatsafavi M., Sadatsafavi M., Lehman A. J., Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis, 2012, vol. 71, no. 9, pp. 1524-1529. doi:10.1136/annrheumdis-2011-200726.
2. Aviña-Zubieta J. A., Choi H. K., Sadatsafavi M., Etminan M., Esdaile J. M., Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum, 2008, vol. 59, no. 12, pp. 1690-1697. doi:10.1002/art.24092.
3. Lacaille D., Avina-Zubieta J. A., Sayre E. C., Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis, 2017, vol. 76, no. 6, pp. 1057-1063. doi:10.1136/annrheumdis-2016-209562.
4. Provan S. A., Lillegraven S., Sexton J., Angel K., Austad C., Haavardsholm E. A., Kvien T. K., Uhlig T. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology, 2020, vol. 59, no. 3, pp. 505–512. doi:10.1093/rheumatology/kez371.
5. Bernardes M., Vieira T. S., Martins M. J., Lucas R., Costa L., Pereira J. G., Ventura F., Martins E. Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers [electronic resource]. Biomed Res Int, 2017. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434312/ (accessed 25.09.2021).
6. Mal K., Kumar R., Mansoor F., Kaur N., Kumar A., Memon S., Rizwan A. Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis. Cureus, 2020, vol. 12, no. 12, pp. e12246. doi: 10.7759/cureus.12246.
7. DeMizio D. J., Geraldino-Pardilla L. B. Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis. Rheumatol Ther, 2020, vol. 7, no. 1, pp. 19-33. doi: 10.1007/s40744-019-00189-0.
8. Błyszczuk P., Szekanecz Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis. RMD Open, 2020, vol. 6, no. 1, pp. e001032. doi: 10.1136/rmdopen-2019-001032.
9. Ntusi N. A. B., Piechnik S. K., Francis J. M., Ferreira V. M., Matthews P. M., Robson M. D., Wordsworth P. B., Neubauer S., Karamitsos T. D. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging, 2015, vol. 8, no. 5, pp. 526-536.
10. Amigues I., Tugcu A., Russo C, Giles J. T., Morgenstein R., Zartoshti A., Schulze C., Flores R., Bokhari S., Bathon J. M. Myocardial inflammation, measured using 18-Fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol, 2019, vol. 71, no. 4, pp. 496-506. doi:10.1002/art.40771.
11. Rudominer R. L., Roman M. J., Devereux R. B., Paget S. A., Schwartz J. E., Lockshin M. D., Crow M. K., Sammaritano L., Levine D. M., Salmon J. E. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum, 2009, vol. 60, no. 1, pp. 22-29. doi:10.1002/art.24148.
12. Cioffi G., Viapiana O., Ognibeni F., Dalbeni A., Gatti D., Adami S., Mazzone C., Faganello G., Di Lenarda A., Rossini M. Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz, 2015, vol. 40, no. 7, pp. 989-996. doi:10.1007/s00059-015-4320-5.
13. Pascale V., Finelli R., Giannotti R., Coscioni E., Izzo R., Rozza F., Caputo D., Moscato P., Iaccarino G., Ciccarelli M. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep, 2018, vol. 8, no. 1, pp. 5867. doi: [10.1038/s41598-018-24323-0].
14. Aslam F., Bandeali S. J., Khan N. A., Alam M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res, 2013, vol. 65, no. 4, pp. 534-543. doi:10.1002/acr.21861.
15. Amigues I., Russo C., Giles J. T., Tugcu A., Weinberg R., Bokhari S., Bathon J. M. Myocardial Microvascular Dysfunction in Rheumatoid Arthritis: Quantitation by 13 N-Ammonia Positron Emission Tomography (PET) /Computed Tomography (CT) PET/CT. Circ Cardiovasc Imaging, 2019, vol. 12, no. 1, pp. e007495. doi: 10.1161/CIRCIMAGING.117.007495.
16. Agca R., Heslinga S. C., Rollefstad S., Heslinga M., McInnes I. B., Peters M. J., Kvien T. K., Dougados M., Radner H., Atzeni F., Primdahl J., Södergren A., Wallberg Jonsson S., van Rompay J., Zabalan C., Pedersen T. R., Jacobsson L., de Vlam K., Gonzalez-Gay M. A., Semb A. G., Kitas G. D., Smulders Y. M., Szekanecz Z., Sattar N., Symmons D. P., Nurmohamed M. T. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis, 2017, vol. 76, no. 1, pp. 17-28. doi:10.1136/annrheumdis-2016-209775.
17. Wang H., Li X., Gong G. Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis. Medicine (Baltimore), 2020, vol. 99, no. 14, pp. e19658. doi: 10.1097/MD.0000000000019658.
18. Lai C. H., Hsieh C. Y., Barnado A., Huang L. C., Chen S. C., Tsai L. M., Shyr Y., Li C. Y. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford), 2020, vol. 59, no. 6, pp. 1355-1363. doi: 10.1093/rheumatology/kez456.
19. Plastiras S. C., Moutsopoulos H. M. Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders. Arrhythm Electrophysiol Rev, 2021, vol. 10, no. 1, pp. 17-25. doi: 10.15420/aer.2020.43.
20. Lai C.H., Hsieh C.Y., Barnado A., Huang L.C., Chen S.C., Tsai L.M., Shyr Y., Li C.Y. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford), 2020, vol. 59, no. 6, pp. 1355-1363. doi: 10.1093/rheumatology/kez456.
21. Masoud S., Lim P. B., Kitas G. D., Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol, 2017, vol. 9, no. 7, pp. 562-573. doi: 10.4330/wjc.v9.i7.562.
22. Myasoedova E., Chandran A., Ilhan B., Major B. T., Michet C. J., Matteson E. L., Crowson C. S. The role of rheumatoid arthritis (rA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis, 2016, vol. 75, no. 3, pp. 560-565. doi:10.1136/annrheumdis-2014-206411.
23. Meissner Y., Zink A., Kekow J., Rockwitz K., Liebhaber A., Zinke S., Gerhold K., Richter A., Listing J., Strangfeld A. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther, 2016, vol. 18, no. 1, pp. 183. doi:10.1186/s13075-016-1077-z.
24. Geraldino-Pardilla L., Russo C., Sokolove J., Robinson W.H., Zartoshti A., Van Eyk J., Fert-Bober J., Lima J., Giles J. T., Bathon J. M. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. Rheumatology (Oxford), 2017, vol. 56, no. 4, pp. 534-540. doi: 10.1093/rheumatology/kew436.
25. Amigues I., Tugcu A., Russo C., Giles J. T., Morgenstein R., Zartoshti A., Schulze C., Flores R., Bokhari S., Bathon J.M. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) is Associated with Disease Activity in Rheumatoid Arthritis. Arthritis Rheumatol, 2019, vol. 71, no. 4, pp. 496-506.
Поступила 08.09.2021

Полнотекстовая статья

Скачать статью

Формат файла: pdf (244.46 Кб)

→ Главная → 2021 том 5, №2